| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/26/2004 | CN1151154C Prepn. process of oxysophocarpine |
| 05/26/2004 | CN1151153C Preparation process of oxysophoridine |
| 05/26/2004 | CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same |
| 05/26/2004 | CN1151151C Method for producing f-methoxy-quinoline carboxylic acids |
| 05/26/2004 | CN1151136C Fused pyridazine compound |
| 05/26/2004 | CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 05/26/2004 | CN1151125C Compounds and methods for treatment of cardiovascular, imflammatory and immune disorders |
| 05/25/2004 | US6740662 Having 2-oxo-1,2-dihydro- functionality; phosphodiesterase inhibitors |
| 05/25/2004 | US6740650 Heterocyclic cytotoxic agents |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/25/2004 | US6740309 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/25/2004 | US6740308 Composition comprising condensation aerosol formed by volatilizing antihistamine under conditions effective to produce heated vapor and condensing to form condensation aerosol particles having less than 5% degradation products |
| 05/25/2004 | US6740307 Delivery of β-blockers through an inhalation route |
| 05/25/2004 | CA2302058C A process for preparing 5-methoxy-4-methyl-2,4-dihydro-3h-1,2,4-triazol-3-one |
| 05/21/2004 | WO2004041819A1 Pyrazolonaphthyridine derivative |
| 05/21/2004 | WO2004041818A1 Anti-infective agents |
| 05/21/2004 | WO2004041817A1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 05/21/2004 | WO2004041788A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 05/21/2004 | WO2004041777A2 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041755A2 Quinazolinone compounds as calcilytics |
| 05/21/2004 | WO2004041285A1 Antiinflammation agents |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041264A1 2-oxo-ethanesulfonamide derivates |
| 05/21/2004 | WO2004041210A2 Antibacterial agents |
| 05/21/2004 | WO2004022558A3 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 05/21/2004 | WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2502429A1 Antiinflammation agents |
| 05/21/2004 | CA2502302A1 Quinazolinone compounds as calcilytics |
| 05/21/2004 | CA2502178A1 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/20/2004 | US20040097736 Can induce biosynthesis of various cytokines and are useful in treatment of a variety of conditions including viral diseases and neoplastic diseases |
| 05/20/2004 | US20040097725 Charge transport compositions and electronic devices made with such compositions |
| 05/20/2004 | US20040097566 For therapy of diseases related to uncontrolled cellular proliferation, useful for modulating lipid and/or carbohydrate metabolism, for therapy of Type II diabetes, hyperglycemia or obesity, inflammatory diseases such as arthritis |
| 05/20/2004 | US20040097545 Quinolinone derivatives |
| 05/20/2004 | US20040097542 To induce the biosynthesis of various cytokines; therapy of viral diseases and neoplastic diseases |
| 05/20/2004 | US20040097541 Pyrazoloisoquinoline derivatives for inhibiting NFkappaB-inducing kinase |
| 05/20/2004 | US20040097540 Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 05/20/2004 | US20040097539 Hsp inductor |
| 05/20/2004 | US20040097537 6-phenylbenzonaphthyridines |
| 05/20/2004 | US20040097535 Suitable for disinfection, deodorisation, and for the general and antimicrobial treatment of the skin and mucosa, and integumentary appendages (hair), especially for the disinfection of hands and wounds |
| 05/20/2004 | US20040097523 Process for making risperidone and intermediates therefor |
| 05/20/2004 | US20040097517 Novel imidazopyridines as cyclin dependent kinase inhibitors |
| 05/20/2004 | US20040097516 For therapy of cancer, inflammation, arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases |
| 05/20/2004 | US20040097511 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc; to regulate effect of chemokine/chemokine receptor |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 05/20/2004 | US20040097492 For inhibiting hepatitis C virus (HCV) polymerase; therapy and prophylaxis of HCV infection |
| 05/20/2004 | US20040097485 For therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease or condition |
| 05/20/2004 | US20040097483 Benzimidazole derivatives useful as histamine H3 antagonists |
| 05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
| 05/20/2004 | US20040096693 Compound of ruthenium complex and electroluminescence device using the same |
| 05/19/2004 | EP1420022A1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 05/19/2004 | EP1420020A1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 05/19/2004 | EP1420019A1 Substituted pyridino pentaazamacrocyle ligands having superoxide dismutase activity |
| 05/19/2004 | EP1420018A1 Pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders |
| 05/19/2004 | EP1420017A1 1,2-dihydro-2-oxo-1,8-naphthyridine derivative |
| 05/19/2004 | EP1419156A1 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| 05/19/2004 | EP1419155A2 Piperidine derivatives as antibacterial agents |
| 05/19/2004 | EP1418909A2 2-amino-4, 5-trisubstituted thiaolyl derivatives and their use against autoimmune diseases |
| 05/19/2004 | EP1289988B1 1,4-diazabicyclo 3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/19/2004 | EP1289987B1 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof |
| 05/19/2004 | EP1273575B1 Diazepane derivatives or salts thereof |
| 05/19/2004 | EP1250334B1 Medicaments useful for the treatment of proliferative diseases |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP0947513B1 Tricyclic amine derivatives |
| 05/19/2004 | EP0942722B1 Tetrahydro-beta-carboline compounds |
| 05/19/2004 | EP0722936B1 Fused pyridazine compound |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
| 05/19/2004 | DE10251019A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| 05/19/2004 | DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1496989A New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 05/19/2004 | CN1150193C Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diaxabicyclo[4.3.o]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/19/2004 | CN1149996C Hexahydro-pyrido(4,3-B) indole derivatives as antipsychotic drugs |
| 05/19/2004 | CN1149993C Pharmaceutical moxifloxacin preparation |
| 05/18/2004 | US6737428 Respiratory syncytial virus |
| 05/18/2004 | US6737424 Alpha-substituted pyridazino quinoline compounds |
| 05/18/2004 | US6737422 Voltage-dependent |
| 05/18/2004 | US6737280 Used as labeling groups in procedures for the detection of analytes; asymmetric monobenzoxanthene compounds |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/18/2004 | CA2214759C Intimal hypertrophy inhibitors |
| 05/13/2004 | WO2004039807A1 Pyridopyrrolizine and pyridoindolizine derivatives |
| 05/13/2004 | WO2004039806A1 Heterocyclic compounds |
| 05/13/2004 | WO2004039805A1 White organic fluorescent compound |
| 05/13/2004 | WO2004039804A1 Amorphous moxifloxacin hydrochloride |
| 05/13/2004 | WO2004039803A2 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 05/13/2004 | WO2004039802A1 Substituted pyrido-pyridazine derivatives which enhance cognition via the gaba-a receptor |
| 05/13/2004 | WO2004039796A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 05/13/2004 | WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 05/13/2004 | WO2004039774A2 Mitotic kinesin inhibitors |
| 05/13/2004 | WO2004039318A2 Anti-infective biaryl compounds |
| 05/13/2004 | WO2004024078A3 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |